WHR1 and arthritic joint disease: It is conceivable that the L19 and G11 antibodies could be used for the molecular imaging of arthritis in patients using positron emission tomography (PET) [46], near-infrared fluorescence [36,47], ultrasound [48] or magnetic resonance imaging (MRI) methodologies [49,50].